← back to search

Alba Sulaj

Heidelberg University · DE
Area of research
Physiology · Clinical Biochemistry
Research interest
Research interests include Diet and metabolism studies, Dietary Effects on Health, Pain Mechanisms and Treatments, and Advanced Glycation End Products research.
h-index
12
citations
507
works
83
NIH funding
primary concept
email

Recent publications

Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape
Nature Communications 2024cited by 28position: middledoi
Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease
Nature Communications 2024cited by 15position: middledoi
Phase Angle of Bioelectrical Impedance Analysis as an Indicator for Diabetic Polyneuropathy in Type 2 Diabetes Mellitus
The Journal of Clinical Endocrinology & Metabolism 2024cited by 11position: middledoi
Sciatic nerve fractional anisotropy and neurofilament light chain protein are related to sensorimotor deficit of the upper and lower limbs in patients with type 2 diabetes
Frontiers in Endocrinology 2023cited by 13position: middledoi
Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study
The Journal of Clinical Endocrinology & Metabolism 2022cited by 58position: firstdoi
Diabetic neuropathy is a generalized phenomenon with impact on hand functional performance and quality of life
European Journal of Neurology 2022cited by 16position: middledoi
Diffusion MRI in Peripheral Nerves: Optimized <i>b</i> Values and the Role of Non-Gaussian Diffusion
Radiology 2021cited by 29position: middledoi
A six-month periodic fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized controlled study
medRxiv 2021cited by 4position: firstdoi
Intermittent fasting has short-term effects on albuminuria, AGE formation and acylcarnitines in patients with type 2 diabetes mellitus
Diabetologie und Stoffwechsel 2021cited by 0position: firstdoi
BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer
Hormone and Metabolic Research 2018cited by 14position: middledoi
ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy
Journal of Diabetes and its Complications 2017cited by 23position: firstdoi
Loss of ALCAM/CD166 partially protects against diabetic nephropathy
Diabetologie und Stoffwechsel 2015cited by 0position: middledoi
CD166/ALCAM Mediates Proinflammatory Effects of S100B in Delayed Type Hypersensitivity
The Journal of Immunology 2013cited by 43position: middledoi
Die Rolle des Pattern Recognition Receptor ALCAM/CD166 bei der diabetischen Nephropathie
Diabetologie und Stoffwechsel 2013cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter P. Nawroth · Endokrinologikum10 papers (2013–2024)Stefan Kopf · University Hospital Schleswig-Holstein9 papers (2015–2024)Stephan Herzig · Heidelberg University6 papers (2017–2024)Ζoltan Κender · University Hospital Heidelberg6 papers (2018–2024)Thomas Fleming · Diabetesinstitut Heidelberg5 papers (2013–2022)Julia Szendroedi · Heidelberg University5 papers (2021–2024)Martin Bendszus · University Hospital and Clinics4 papers (2021–2024)Aurelio A. Teleman · German Cancer Research Center3 papers (2021–2022)Hannelore Bartl · University Hospital Heidelberg3 papers (2021–2023)Jan B. Groener · University Hospital Heidelberg3 papers (2018–2024)Ekaterina von Rauchhaupt · Ludwig-Maximilians-Universität München3 papers (2021–2023)Johann M. E. Jende · German Cancer Research Center3 papers (2022–2024)Maik Brune · University Hospital Heidelberg3 papers (2018–2022)Jürgen G. Okun · Heidelberg University3 papers (2021–2022)Felix T. Kurz · University of Geneva3 papers (2022–2024)Christoph Mooshage · Heidelberg University2 papers (2023–2024)Elisabeth Kliemank · University Hospital Heidelberg2 papers (2021–2022)Vedat Schwenger · University of Stuttgart2 papers (2015–2017) · 2 papers (2013–2015)Varun Kumar · University Hospital Heidelberg2 papers (2021–2022)